By restraining AhR with clofazimine (CLF), there was a significant decline in the proliferation of SCLC cells induced by Kyn, along with an elevation in apoptosis and an arrest of the cell cycle in the G2/M phase. The gene discussed is AHR; the disease is small cell lung carcinoma.